15 -2 (76) 2025 - Agababyan L.R., Usmankulova X.M. - THE PLACE OF POCS IN THE PROBLEM OF FEMALE INFERTILITY

THE PLACE OF POCS IN THE PROBLEM OF FEMALE INFERTILITY

Agababyan L.R. - Samarkand State Medical University

Usmankulova X.M. - Samarkand State Medical University

Resume

Polycystic ovary syndrome (PCOS) is a heterogeneous complex disorder characterized by oligo-anovulation, hyperandrogenism and/or hyperandrogenemia, and polycystic ovarian morphological changes. Interest in PCOS encompasses several specific aspects, including reproductive, cosmetic, and medical. Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder characterized by both metabolic and hormonal disorders and is a major cause of infertility in women. Much information has emerged in recent years to define the diagnostic criteria for this syndrome. In addition to hormonal aspects and metabolic abnormalities such as insulin resistance and obesity, susceptibility to developing earlier than expected glucose tolerance, the idea that these aspects should be included in the diagnostic criteria in order to develop potential therapeutic strategies is being considered. In addition, family history of SPCJ in families and in both female and male relatives may demonstrate stigmata of the syndrome, suggesting a genetic background.

Key words: PCOS, multicystic ovaries, infertility, pharmacotherapy, diagnosis, hormones.

First page

80

Last page

85

For citation:Agababyan L.R., Usmankulova X.M. - THE PLACE OF POCS IN THE PROBLEM OF FEMALE INFERTILITY //New Day in Medicine 2(76)2025 80-85 https://https://newdayworldmedicine.com/en/new_day_medicine/2-75-2025

List of References

  1. Али Р.М. и др. Генетические ассоциации между полиморфными локусами генов ферментов антиоксидантной защиты GPX4 (rs713041), GSTP1 (rs1695) и PON1 (rs662) и синдромом поликистозных яичников у российских женщин //Медицинская генетика. – 2024;23(3):21-30.
  2. Беглова А.Ю. и др. Молекулярно-генетические особенности у женщин с синдромом поликистозных яичников (СПКЯ) //Мать и дитя в Кузбассе. 2019;3:48-53.
  3. Гасиева Д.М. и др. Синдром поликистозных яичников: новые и перспективные варианты лечения //Problems of Endocrinology. 2024;70(4):103.
  4. Журин Н. В. и др. Клинико-анамнестические факторы риска бесплодия при спкя и наружном генитальном эндометриозе //Мать и дитя в Кузбассе. 2024;2(97):104-108.
  5. Ефименко В. В. и др. Новые аспекты в диагностике и лечении синдрома поликистозных яичников. //Медицинский Совет. 2024;(6):140-147 [Электронный ресурс].
  6. Ибрагимова, Надия Сабировна, Баходир Фикриевич Ибрагимов, and Машхура Акбар Кизи Мамадиёрова. "Синдром поликистозных яичников: основные моменты." //Вестник науки и образования (2021;2/2(105):69-71.
  7. Каширина Е.Ж., Маклакова Т.П. Особенности прегравидарной подготовки при эндокринных заболеваниях. (Обзор литературы) //Медицина в Кузбассе. 2024;23(2).
  8. Кудрявцева Е.В. и др. Сексуальная функция у женщин с бесплодием неясного генеза: особенности и влияние на репродуктивное здоровье //Consilium Medicum. 2024;26(7):415-419.
  9. Усмонкулова Х.М. и др. Особенности индукции овуляции женщин с синдромом поликистозных яичников //"England" modern psychology and pedagogy: problems and solution. 2023;10(1).
  10. Bjekić-Macut J, Vukašin T, Velija-Ašimi Z, Bureković A, Zdravković M, Andrić Z, Branković M, Crevar-Marinović S, Madić T, Stanojlović O, Milutinović DV, Livadas S, Mastorakos G. Polycystic Ovary Syndrome: A Contemporary Clinical Approach. Curr Pharm Des. 2021;27(36):3812-3820. doi: 10.2174/1381612827666210119104721. PMID: 33463457
  11. Chiaffarino F. et al. Prevalence of polycystic ovary syndrome in European countries and USA: A systematic review and meta-analysis //European Journal of Obstetrics Gynecology and Reproductive Biology 2022;279:159-170.
  12. Chiaffarino F. et al. Prevalence of polycystic ovary syndrome in European countries and USA: A systematic review and meta-analysis //European Journal of Obstetrics Gynecology and Reproductive Biology. 2022;279:159-170.
  13. Cook H., Brennan K., Azziz R. Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? //Fertil Steril. 2011;96:1266-70.
  14. Dunaif A, Fauser BC. Renaming PCOS-a two-state solution. //J Clin Endocrinol Metab. 2013;98:4325-8.
  15. Palomba S, Daolio J, La Sala GB. Oocyte quality and competence in women with polycystic ovary syndrome. //Trend Endocrinol Metab. 2017;28:186-98.
  16. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.
  17. Rusanova N.E. Infertility and fertility: demographic problems of assisted reproduction //Population and Economics. 2024;8(1):156-167.
  18. Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. //Nat Rev Dis Primers. 2024 Apr 18;10(1):27. doi: 10.1038/s41572-024-00511-3. PMID: 38637590;
  19. Zhu J. et al. Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome //The Journal of Clinical Endocrinology Metabolism. 2024;109(2):380-388.
  20. Wang Y. et al. Trends in the burden of female infertility among adults aged 20–49 years during 1990–2019: an analysis of data from the Global Burden of Disease Study 2019 //BMJ open. 2024;14(7): e084755.

    file

    download